Imricor Medical Systems, Inc. (ASX: IMR)
Australia
· Delayed Price · Currency is AUD 1.025
+0.070 (7.33%)
Dec 20, 2024, 4:10 PM AEST
Imricor Medical Systems Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Net Income | -20.26 | -22.63 | -17.36 | -19.73 | -12.45 | -13.29 | Upgrade
|
| Depreciation & Amortization | 0.89 | 0.86 | 0.93 | 0.69 | 0.53 | 0.26 | Upgrade
|
| Other Amortization | - | 0.01 | 0.1 | - | - | 4.3 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0 | 0 | 0 | 0.08 | - | -0.03 | Upgrade
|
| Stock-Based Compensation | 0.19 | 0.54 | 0.32 | 1.15 | 0.82 | 0.53 | Upgrade
|
| Other Operating Activities | 4.89 | 6.34 | 0.69 | 0.71 | 0.41 | 2.16 | Upgrade
|
| Change in Accounts Receivable | -0.16 | -0.22 | -0.07 | 0.15 | 0.07 | -0.16 | Upgrade
|
| Change in Inventory | -0.42 | -0.92 | -0.44 | -0.18 | -2.06 | -0.85 | Upgrade
|
| Change in Accounts Payable | 0.26 | 1.91 | -0.4 | 0.15 | -0.28 | 0.25 | Upgrade
|
| Change in Unearned Revenue | 0 | 0.86 | -0.17 | 0.09 | -0.02 | 0.01 | Upgrade
|
| Change in Other Net Operating Assets | -0.19 | 0.27 | -0.11 | -0.61 | 0.74 | 0.18 | Upgrade
|
| Operating Cash Flow | -14.79 | -12.98 | -16.51 | -17.49 | -12.23 | -6.63 | Upgrade
|
| Capital Expenditures | -0.04 | -0.08 | -0.24 | -0.63 | -0.74 | -0.36 | Upgrade
|
| Investment in Securities | - | - | - | -0.07 | - | - | Upgrade
|
| Other Investing Activities | - | - | - | - | -0.03 | -0.16 | Upgrade
|
| Investing Cash Flow | -0.04 | -0.08 | -0.24 | -0.7 | -0.77 | -0.53 | Upgrade
|
| Long-Term Debt Issued | - | 3.31 | 3.16 | - | - | 3.45 | Upgrade
|
| Long-Term Debt Repaid | - | -0.84 | -1.2 | -0.58 | -0.38 | -0.22 | Upgrade
|
| Net Debt Issued (Repaid) | -0.15 | 2.46 | 1.97 | -0.58 | -0.38 | 3.23 | Upgrade
|
| Issuance of Common Stock | 15.68 | 5.85 | 2.05 | 12.17 | 33.41 | 7.22 | Upgrade
|
| Other Financing Activities | -0.7 | -0.1 | -0.07 | - | - | - | Upgrade
|
| Financing Cash Flow | 14.82 | 8.21 | 3.94 | 11.59 | 33.02 | 10.45 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | -0.01 | -0.02 | -0.03 | 0.07 | 0.17 | Upgrade
|
| Net Cash Flow | -0.01 | -4.86 | -12.83 | -6.62 | 20.09 | 3.46 | Upgrade
|
| Free Cash Flow | -14.83 | -13.06 | -16.75 | -18.11 | -12.97 | -6.99 | Upgrade
|
| Free Cash Flow Margin | -1799.58% | -2121.66% | -2052.56% | -2601.63% | -1847.52% | -1093.12% | Upgrade
|
| Free Cash Flow Per Share | -0.08 | -0.08 | -0.11 | -0.14 | -0.12 | -0.12 | Upgrade
|
| Cash Interest Paid | 0.04 | 0.05 | 0.07 | 0.18 | 0.3 | 0.28 | Upgrade
|
| Levered Free Cash Flow | -8.42 | -6.08 | -10.6 | -11.34 | -8.36 | -0.78 | Upgrade
|
| Unlevered Free Cash Flow | -8.41 | -6.06 | -10.59 | -11.27 | -8.17 | -4.43 | Upgrade
|
| Change in Net Working Capital | -0.43 | -3.16 | 0.82 | -0.18 | 1.3 | 0.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.